Stamford Pharmaceuticals announced today that Associate Professors Greg Siller and Sherrif Ibrahim will be Principal Investigators for the company’s initial Pilot phase of its registration program in Australia and the US

August 1st, 2019 Stamford Pharmaceuticals announced today the engagement with Assoc. Professors Greg Siller and Sherrif Ibrahim to serve as lead investigators and initial centers for the company’s registration program.
Press Release: SP Investigators Sites